Cargando…
Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine
In this study, we investigated drug profile of 24 anticancer drugs tested against a large number of cell lines in order to understand the relation between drug resistance and altered genomic features of a cancer cell line. We detected frequent mutations, high expression and high copy number variatio...
Autores principales: | Gupta, Sudheer, Chaudhary, Kumardeep, Kumar, Rahul, Gautam, Ankur, Nanda, Jagpreet Singh, Dhanda, Sandeep Kumar, Brahmachari, Samir Kumar, Raghava, Gajendra P. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814902/ https://www.ncbi.nlm.nih.gov/pubmed/27030518 http://dx.doi.org/10.1038/srep23857 |
Ejemplares similares
-
A web-based resource for designing therapeutics against Ebola Virus
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2016) -
A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer
por: Gupta, Sudheer, et al.
Publicado: (2016) -
Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines
por: Singh, Harinder, et al.
Publicado: (2016) -
CancerDR: Cancer Drug Resistance Database
por: Kumar, Rahul, et al.
Publicado: (2013) -
In Silico Approach for Predicting Toxicity of Peptides and Proteins
por: Gupta, Sudheer, et al.
Publicado: (2013)